| (CCTG) ME.13/STOP-GAP | A Randomized Phase III Study of Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP) | Dr Elaine McWhirter | Open to recruitment | NCT02821013 |
| (CCTG) ME.15 / MelMarT-II | Melanoma Margins Trial: A Phase III, Multi-centre, Multi-national Randomized Control Trial Investigating 1cm vs 2cm Wide Excision Margins for Primary Cutaneous Melanoma (MelMarT-II) | Dr Valerie Francescutti | Open to recruitment | NCT03860883 |
| (Merck) MK-3475-630 | A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Pembrolizumab versus Placebo as Adjuvant Therapy Following Surgery and Radiation of High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) | Dr Elaine McWhirter | Open to recruitment | NCT03833167 |
Find a Trial
Contact Us